Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
J Biol Chem
2010 Nov 19;28547:37082-91. doi: 10.1074/jbc.M110.152033.
Show Gene links
Show Anatomy links
Structural basis for the cAMP-dependent gating in the human HCN4 channel.
Xu X
,
Vysotskaya ZV
,
Liu Q
,
Zhou L
.
???displayArticle.abstract???
Hyperpolarization-activated cAMP-regulated (HCN) channels play important physiological roles in both cardiovascular and central nervous systems. Among the four HCN isoforms, HCN2 and HCN4 show high expression levels in the human heart, with HCN4 being the major cardiac isoform. The previously published crystal structure of the mouse HCN2 (mHCN2) C-terminal fragment, including the C-linker and the cyclic-nucleotide binding domain (CNBD), has provided many insights into cAMP-dependent gating in HCN channels. However, structures of other mammalian HCN channel isoforms have been lacking. Here we used a combination of approaches including structural biology, biochemistry, and electrophysiology to study cAMP-dependent gating in HCN4 channel. First we solved the crystal structure of the C-terminal fragment of human HCN4 (hHCN4) channel at 2.4 Å. Overall we observed a high similarity between mHCN2 and hHCN4 crystal structures. Functional comparison between two isoforms revealed that compared with mHCN2, the hHCN4 protein exhibited marked different contributions to channel function, such as a ∼3-fold reduction in the response to cAMP. Guided by structural differences in the loop region between β4 and β5 strands, we identified residues that could partially account for the differences in response to cAMP between mHCN2 and hHCN4 proteins. Moreover, upon cAMP binding, the hHCN4 C-terminal protein exerts a much prolonged effect in channel deactivation that could have significant physiological contributions.
Bell,
Changes in local S4 environment provide a voltage-sensing mechanism for mammalian hyperpolarization-activated HCN channels.
2004, Pubmed,
Xenbase
Bell,
Changes in local S4 environment provide a voltage-sensing mechanism for mammalian hyperpolarization-activated HCN channels.
2004,
Pubmed
,
Xenbase
Biel,
Hyperpolarization-activated cation channels: from genes to function.
2009,
Pubmed
Brunger,
Version 1.2 of the Crystallography and NMR system.
2007,
Pubmed
Chen,
Properties of hyperpolarization-activated pacemaker current defined by coassembly of HCN1 and HCN2 subunits and basal modulation by cyclic nucleotide.
2001,
Pubmed
,
Xenbase
Chen,
The S4-S5 linker couples voltage sensing and activation of pacemaker channels.
2001,
Pubmed
,
Xenbase
Chen,
Voltage sensor movement and cAMP binding allosterically regulate an inherently voltage-independent closed-open transition in HCN channels.
2007,
Pubmed
,
Xenbase
Collaborative Computational Project, Number 4,
The CCP4 suite: programs for protein crystallography.
1994,
Pubmed
Colquhoun,
Binding, gating, affinity and efficacy: the interpretation of structure-activity relationships for agonists and of the effects of mutating receptors.
1998,
Pubmed
Craven,
Salt bridges and gating in the COOH-terminal region of HCN2 and CNGA1 channels.
2004,
Pubmed
,
Xenbase
Craven,
C-terminal movement during gating in cyclic nucleotide-modulated channels.
2008,
Pubmed
,
Xenbase
Decher,
Voltage-dependent gating of hyperpolarization-activated, cyclic nucleotide-gated pacemaker channels: molecular coupling between the S4-S5 and C-linkers.
2004,
Pubmed
,
Xenbase
DiFrancesco,
Cardiac pacemaker I(f) current and its inhibition by heart rate-reducing agents.
2005,
Pubmed
Emsley,
Coot: model-building tools for molecular graphics.
2004,
Pubmed
Flynn,
Structure and rearrangements in the carboxy-terminal region of SpIH channels.
2007,
Pubmed
,
Xenbase
Gaborit,
Regional and tissue specific transcript signatures of ion channel genes in the non-diseased human heart.
2007,
Pubmed
Ganetzky,
The eag family of K+ channels in Drosophila and mammals.
1999,
Pubmed
Harzheim,
Cardiac pacemaker function of HCN4 channels in mice is confined to embryonic development and requires cyclic AMP.
2008,
Pubmed
Humphrey,
VMD: visual molecular dynamics.
1996,
Pubmed
Jan,
A superfamily of ion channels.
1990,
Pubmed
Johnson,
Rotational movement during cyclic nucleotide-gated channel opening.
2001,
Pubmed
,
Xenbase
Ludwig,
Mouse models for studying pacemaker channel function and sinus node arrhythmia.
2008,
Pubmed
Ludwig,
Two pacemaker channels from human heart with profoundly different activation kinetics.
1999,
Pubmed
Mangoni,
Genesis and regulation of the heart automaticity.
2008,
Pubmed
McCoy,
Phaser crystallographic software.
2007,
Pubmed
Milanesi,
Familial sinus bradycardia associated with a mutation in the cardiac pacemaker channel.
2006,
Pubmed
Mistrík,
The murine HCN3 gene encodes a hyperpolarization-activated cation channel with slow kinetics and unique response to cyclic nucleotides.
2005,
Pubmed
Nof,
The Contribution of HCN4 to normal sinus node function in humans and animal models.
2010,
Pubmed
Otwinowski,
Processing of X-ray diffraction data collected in oscillation mode.
1997,
Pubmed
Sanguinetti,
Mutations of the S4-S5 linker alter activation properties of HERG potassium channels expressed in Xenopus oocytes.
1999,
Pubmed
,
Xenbase
Schulze-Bahr,
Pacemaker channel dysfunction in a patient with sinus node disease.
2003,
Pubmed
Stieber,
Functional expression of the human HCN3 channel.
2005,
Pubmed
Stieber,
Molecular basis for the different activation kinetics of the pacemaker channels HCN2 and HCN4.
2003,
Pubmed
Stillitano,
Molecular basis of funny current (If) in normal and failing human heart.
2008,
Pubmed
Studier,
Protein production by auto-induction in high density shaking cultures.
2005,
Pubmed
Taraska,
Mapping the structure and conformational movements of proteins with transition metal ion FRET.
2009,
Pubmed
Thompson,
Multiple sequence alignment using ClustalW and ClustalX.
2002,
Pubmed
Tibbs,
A state-independent interaction between ligand and a conserved arginine residue in cyclic nucleotide-gated channels reveals a functional polarity of the cyclic nucleotide binding site.
1998,
Pubmed
,
Xenbase
Ueda,
Functional characterization of a trafficking-defective HCN4 mutation, D553N, associated with cardiac arrhythmia.
2004,
Pubmed
Ulens,
Regulation of hyperpolarization-activated HCN channels by cAMP through a gating switch in binding domain symmetry.
2003,
Pubmed
,
Xenbase
Verkerk,
Pacemaker activity of the human sinoatrial node: role of the hyperpolarization-activated current, I(f).
2009,
Pubmed
Wainger,
Molecular mechanism of cAMP modulation of HCN pacemaker channels.
2001,
Pubmed
Wang,
Activity-dependent regulation of HCN pacemaker channels by cyclic AMP: signaling through dynamic allosteric coupling.
2002,
Pubmed
,
Xenbase
Wang,
Regulation of hyperpolarization-activated HCN channel gating and cAMP modulation due to interactions of COOH terminus and core transmembrane regions.
2001,
Pubmed
,
Xenbase
Zagotta,
Structural basis for modulation and agonist specificity of HCN pacemaker channels.
2003,
Pubmed
Zagotta,
Structure and function of cyclic nucleotide-gated channels.
1996,
Pubmed
Zhou,
Pathway and endpoint free energy calculations for cyclic nucleotide binding to HCN channels.
2008,
Pubmed
Zhou,
A conserved tripeptide in CNG and HCN channels regulates ligand gating by controlling C-terminal oligomerization.
2004,
Pubmed
,
Xenbase
Zhou,
Gating of HCN channels by cyclic nucleotides: residue contacts that underlie ligand binding, selectivity, and efficacy.
2007,
Pubmed
,
Xenbase
Zolles,
Pacemaking by HCN channels requires interaction with phosphoinositides.
2006,
Pubmed
,
Xenbase
